DeAnne Stolarik - Concepedia

Author

DeAnne Stolarik

Also Known As

D. Stolarik, DeAnne F Stolarik, DeAnne F. Stolarik, DeAnne Stolarik, Deanne F. Stolarik, Deanne Stolarik, Stolarik, D.F., Stolarik, DeAnne

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)Abbott Fund Purdue University West Lafayette University of Illinois Chicago Abbott (United States)

About

DeAnne Stolarik is an author at AbbVie (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	666
2	Natural Sciences	5	5	230
3	Health Sciences	3	3	116
4	Anesthesia	2	2	81
5	Social Sciences	1	1	35

DeAnne Stolarik

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez, Molecular Cancer Research	2015	257
Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport Venecia R. Wilson, Xiaochun Lou, Donald J. Osterling, Journal of Controlled Release Membrane Mass TransportDiffusion ResistanceTransport PhenomenaVitro DissolutionPhase Separation	2018	153
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-<i>N</i>-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Jeffrey J. Rohde, Marina Pliushchev, Bryan K. Sorensen, Journal of Medicinal Chemistry Medicinal ChemistryPharmacological StudyBiochemistryMedicineNatural Sciences	2006	76
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease Matthew Rosebraugh, Eric A. Voight, Ehab M. Moussa, Annals of Neurology	2021	76
Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors Bryan K. Sorensen, Martin Winn, Jeff Rohde, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryAdamantane SulfoneBiochemistryMedicine	2006	64
Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance Venecia R. Wilson, Xiaochun Lou, Donald J. Osterling, Scientific Reports	2020	61
The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class Richard J. Sciotti, Marina Pliushchev, Paul E. Wiedeman, Bioorganic & Medicinal Chemistry Letters Antifungal AgentBioorganic ChemistryNovel SeriesMedicineDrug Discovery	2002	60
Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530) Rolf Wagner, John T. Randolph, Sachin Patel, Journal of Medicinal Chemistry	2018	53
Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis <i>In Vivo</i> John T. Randolph, Matthew J. O’Connor, Fei Han, Journal of Medicinal Chemistry	2023	42
Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica). Allison J Thiede, Kelly García, DeAnne Stolarik, PubMed Opioid BuprenorphinePain MedicinePharmacotherapyTransdermal BuprenorphineSus Scrofa Domestica	2014	41

Page 1